Table Of Content

Journal of Hepatology, 1992; 14: 430-433 © 1992 Elsevier Science Publishers B.V. All rights reserved. 0168-8278/92/$5.00 Table of Contents (Vol. 14) Number 1 Editor’s Note Leader Immunosuppressive therapy for primary biliary cirrhosis 1 R. Beukers and S.W. Schalm (The Netherlands) Regular Papers Experimental dissolution of pigment gallstone material using alkaline EDTA and adjuvant bile salts/non-bile salt detergents, thiols and urea, with respect to local chemolitholysis 7 U. Wosiewitz, F. Sabinski, C. Haus, S. Gildiituna and U. Leuschner (F.R.G.) Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosyl-L-methionine 16 P. Muriel and M. Mourelle (México) Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis 22 R. Beukers, R.A.A. van Zanten and S.W. Schalm (The Netherlands) Expression of insulin-like growth factor II (IGF-II) and IGF-II, IGF-I and insulin receptors mRNAs in isolated non-parenchymal rat liver cells 30 F. Zindy, E. Lamas, S. Schmidt, A. Kirn and C. Brechot (France) Clinical backgrounds of the patients having different types of hepatitis C virus genomes 35 N. Takada, S. Takase, N. Enomoto, A. Takada and T. Date (Japan) Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency 41 M. Yamazaki, H. Suzuki, Y. Sugiyama, T. Iga and M. Hanano (Japan) Autoantibodies in experimental autoimmune hepatitis 48 A.W. Lohse, S. Brunner, A. Kyriatsoulis, M. Manns and K.-H. Meyer zum Biischenfelde (F.R.G.) Utilization of ATP-depleted cells in the analysis of taurocholate uptake by isolated rat hepatocytes 54 M. Yamazaki, Y. Sugiyama, H. Suzuki, T. Iga and M. Hanano (Japan) Effect of the terpenic compound epomediol on biliary secretion and bile composition in the rat 64 G. Zanninelli, A. Tavanti,M.-E. Munoz and G.L. Ricci (Italy) Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity 71 E. Lotterer, A.M. Gressner, J. Kropf, E. Grobe, D. von Knebel and J. Bircher (F.R.G.) The effect of an eucaloric high carbohydrate diet on circulating levels of glucose, fructose and non-esterified fatty acids in patients with cirrhosis 78 A. Avgeniros, D. Harry, S. Bousboulas, E. Theodossiadou, V. Komesidou, A. Pallikari, S. Raptis and N. McIntyre (Greece, U.K.) Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis 88 A.J. Czaja, H.F. Taswell, J. Rakela and C. Schimek (Japan) Hepatic haemodynamics and microvascular architecture after portal venular embolization in the rat 94 Y. Shibayama, K. Hashimoto and K. Nakata (Japan) The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage 99 P.A. McCormick, M.Y. Morgan, A. Phillips, T.P. Yin, N. McIntyre and A.K. Burroughs (U.K.) Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications 104 J.G. O’Grady, H.M. Smith, S.E. Davies, H.M. Daniels, P.T. Donaldson, K.C. Tan, B. Portmann, G.J.M. Alexander and R. Williams (U.K.) Hepatitis C virus antibody secretion in vitro by peripheral blood lymphocytes 112 H. Lohr, B. Fleischer, G. Michel, S. Rossol, G. Hess, K.-H. Meyer zum Biischenfelde and M. Manns (F.R.G.) Reviews Mechanism of bile acid-induced HCO;-rich hypercholeresis. An analysis based on quantitative acid-base chemistry 118 M.S. Anwer (U.S.A.) Endoscopic management of biliary tract obstruction in the 1990s 127 M.R. Jacyna and J.A. Summerfield (U.K.) List of Referees (Vols. 12 and 13) 133 26th EASL meeting, Young Investigator Awards 135 Announcements 136 Corrigendum 137 Forthcoming papers Numbers 2 and 3 Publishers’ note Leaders Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy 141 C.C.D. van der Rijt and S.W. Schalm (The Netherlands) Large-volume paracentesis and volume re-expansion: can synthetic plasma expanders safely replace albumin? 143 F. Salerno (Italy) Regular Papers Nitric oxide production by monocytes in alcoholic liver disease 146 N.C.A. Hunt and R.D. Goldin (U.K.) Reversible bile acid changes in bile duct obstruction and its potential for hepatocellular injury 151 G.C. Vitale, Y. Siow, P.R. Baker and A. Cuschieri (U.S.A., U.K.) Caffeine clearance in cirrhosis. The value of simplified determinations of liver metabolic capacity 157 F.W. Lewis and W.G. Rector Jr. (U.S.A.) Protein C in patients with alcoholic cirrhosis and other liver diseases 163 H. Bell, O.R. @degaard, T. Andersson and N. Raknerud (Norway) Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunochemical study 168 F.J.W. ten Kate, S.W. Schalm, P.J.A. Willemse, A.P.R. Blok, R.A. Heijtink and O.T. Terpstra (The Netherlands) Selenium in chronic liver disease 176 P.J. Thuluvath and D.R. Triger (U.K.) Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factor and clinical features 183 F. Farinati, S. Fagiuoli, N. De Maria, M. Chiaramonte, V. Aneloni, S. Ongaro, M. Salvagnini and R. Naccarato (Italy) Per-rectal portal scintigraphy with technetium-99m pertechnetate for the early diagnosis of cirrhosis in patients with chronic hepatitis 188 A. D’Arienzo, L. Celentano, L. Cimino, A. Panarese, C. Lancia, E. Vergara, G. Castaldo, G. Oriani, G. Squame, G. Budillon and G. Mazzacca (Italy) Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects 194 K.J. van Erpecum, G.P. van Berge Henegouwen, M.F.J. Stolk, W.P.M. Hopman, J.B.M.J. Jansen and C.B.H.W. Lamers (The Netherlands) Polycystic hydatid disease (Echinococcus vogeli). Clinical, laboratory and morphological findings in nine Brazilian patients 203 U.G. Meneghelli, A.L.C. Martinelli, M.A.S. Llorach Velludo, A.D. Bellucci, J.E. Magro and M.L.P. Barbo (Brazil) Phenotypical modulation of liver fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation 211 M. Pinzani, P. Gentilini and H.E. Abboud (Italy, U.S.A.) Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon 221 G. Pastore, T. Santantonio, M. Milella, L. Monno, N. Mariano, R. Moschetta and L. Pollice (Italy) Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice 226 M. Cadrin, N. Marceau and S.W. French (Canada) Enhanced expression of HLA class I by inhibited replication of hepatitis B virus 232 T. Takehara, N. Hayashi, K. Katayama, K. Ueda, T. Towata, A. Kasahara, H. Fusamoto and T. Kamada (Japan) Effects of an increase in protein intake on hepatic efficacy for urea synthesis in healthy subjects and in patients with cirrhosis 237 O. Hamberg, K. Nielsen and H. Vilstrup (Denmark) Pathophysiology of elevated ascites fluid cholesterol in malignant ascites. Increased ascites to serum relation of proteins and lipoproteins in patients with peritoneal carcinomatosis as compared to patients with cirrhosis of the liver 244 D. Jiingst, Y. Xie and A.L. Gerbes (Germany) Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis 249 B.A. Runyon, M.R. Antillon and J.G. McHutchison (U.S.A.) Hepatic oxidant and antioxidant systems in portacaval-shunted rats 253 J.N. Benoit, M.B. Grisham, C.L. Mesh, R.J. Korthuis and D.N. Granger (U.S.A.) Increased transforming growth factor-f1 gene expression in human liver disease 259 G. Annoni, F.R. Weiner and M.A. Zern (U.S.A.) Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques 265 I.J. Cox, D.K. Menon, J. Sargentoni, D.J. Bryant, A.G. Collins, G.A. Coutts, R.A. Iles, J.D. Bell, I.S. Benjamin, S. Gilbey, H.J.F. Hodgson and M.Y. Morgan (U.K.) Aprindine-induced hepatic granulomata 276 M. Elisaf, S. Stefanaki-Nikou, M. Voulgarelis, C. Masalas and E.V. Tsianos (Greece) Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure 280 J.M. Salmeron, L. Tit6, A. Rimola, A. Mas, M.A. Navasa, J. Llach, A. Ginés, P. Ginés, V. Arroyo and J. Rodés (Spain) Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment 286 L. Lega, A. Vierucci, B.S. Blumberg, G. Saracco, M. Rizzetto, M. Zhu and M.A. Feitelson (Italy) Interferon-y receptor expression in chronic hepatitis B virus infection 294 J.Y.N. Lau, A.G. Morris, G.J.M. Alexander and R. Williams (U.K.) Effect of amphotericin B on hepatic cytochrome P-450 and glucose-6-phosphatase in the rat 300 H. Heidemann, U. Holzléhner, J. Heydemann, T. Freitag and G. Inselmann (Germany) 432 Failure of acyclovir to enhance the antiviral effect of a lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi- centre randomized control trial L. Berk, S.W. Schalm, R.A. de Man, R.A. Heytink, P. Berthelot, C. Brechot, B. Boboc, F. Degos, P. Marcellin, J.-P. Benhamou, G. Hess, S. Rossol, K.-H. Meyer zum Biischenfelde, R.A.F.M. Chamuleau, P.L.M. Jansen, H.W. Reesink, B. Meyer, C. Beglinger, G.A. Stalder, J.W. den Ouden-Muller and M. de Jong (The Netherlands, Germany, Switzerland) Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study 310 E. Fassio, R. Terg, G. Landeira, R. Abecasis, M. Salemne, A. Podesta, P. Rodriguez, D. Levi and D. Kravetz (Argentina) Steatosis associated with immotile cilia syndrome: an unrecognized relationship? 317 F. Paolucci, S. Cinti, A. Cangiotti, N. Oggiano, P.L. Giorgi, R. Mancini, A.M. Jezequel and F. Orlandi (Italy) Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis 325 R. Perdigoto, H.A. Carpenter and A.J. Czaja (U.S.A.) Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong Kong 332 A.S.F. Lok, A. Wong, S. Sporton, C. Lai, V. Liu and H. Chung (Hong Kong) Uridine catabolism by the isolated perfused rat liver 335 A. Holstege, H.-M. Gengenbacher, Jehle L. and W. Gerok (Germany) Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas 342 C. Challen, K. Guo, J.D. Collier, D.C avanagh and M.F. Bassendine (U.K.) Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis 347 R. Brenard, R. Moreau, E. Pussard, B. Champigneulle, C. Gaudin, A. Hadengue, A. Braillon and D. Lebrec (France) Detection of srrum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B 357 S. Gayno, P. Marcelin, M.A. Loriot, M. Martinot-Peignoux, P. Levy, S. Erlinger and J.P. Benhamou (France) Hepatic expression of type A and type B receptors for tumor necrosis factor 361 R. Volpes, J.J. van den Oord, R. de Vos and V.J. Desmet (Belgium) Serological response and detection of viraemia in acute hepatitis C virus infection 370 S. Dourakis, J. Brown, U. Kumar, P. Karayiannis, P. Kernoff, J. Chiba, H. Ohba, T. Miyamura, I. Saito, J. Monjardino and H. Thomas (U.K., Japan) Rapid Publications c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma 377 J.D. Collier, K. Guo, J. Mathew, F.E.B. May, M.K. Bennett, I.P. Corbett, M.F. Bassendine and A.D. Burt (U.K.) Hepatitis C viremia and anti-HCV antibodies in alcoholics 381 B. Nalpas, V. Thiers, S. Pol, F. Driss, V. Thepot, P. Berthelot and C. Brechot (France) Reviews Determinants in the hepatic uptake of organic anions 385 C. Tiribelli (Italy) Immunologic and molecular basis of viral persistence. The hepatitis B virus model 391 V. Barnaba and F. Balsano (Italy) Consensus Report Early diagnosis of hepatocellular carcinoma in Italy. A summary of a Consensus Development Conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF) 401 M. Colombo (Italy) Letters to the Editor Gilbert’s syndrome — a possible cause of hyperbilirubinemia after orthotopic liver transplantation J.C. Arnold, G. Otto, T. Kraus, B. Kommerell and L. Theilmann (Germany) HCV in non-replicative chronic HBV infection H.M. Smith, H.M. Daniels, C.J. Tibbs, J.Y.N. Lau and R. Williams (U.K.) Detection of hepatitis C virus RNA in liver needle biopsies by polymerase chain reaction I.D. Diamantis, C.E. McGandy, I. Pult, J.-J. Widmann, F. Gudat and L. Bianchi (Switzerland) Hormonal treatment of hepatocellular carcinoma M.L. Wilkinson and A. Forbes (U.K.) Problems in treating chronic HDV infection R. King, J.Y.N. Lau and R. Williams (U.K.) Toxicity of diclofenac to isolated hepatocytes G. Schmitz, I. Stauffert, H. Sippel, H. Lepper and C.-J. Estler (Germany) Low rate of hepatitis C virus (HCV) transmission within the family P. Dény, D. Roulot, C. Asselot, M. Rauzy, J. Rautureau and T. Coste (France) Liver transplantation in carriers of the HBsAG: role of short-term passive prophylaxis with immunoglobulin P.J. Johnson (U.K.) Immunoblot assay as diagnostic test for hepatitis C virus infection M. Mateos, I. Martos, R. Moreno and C. Camero (Spain) Treatment of chronic type D hepatitis and concomitant human immunodeficiency infection with a-interferon M. Buti, R. Esteban, R. Jardi, F. Rodriguez-Frias, H. Allende, M. Cotrina and J. Guardia (Spain) Hepatocellular carcinoma. Frequency of diffuse inhomogenous forms in ultrasonography and comparative value of alphafetoprotein and ultrasonically guided fine needle aspiration biopsy D. Sautereau, P. Berry, F. Cessot, A. Gainant and B. Pillegand (France) Low prevalence of hepatitis C virus genome detected by PCR in serum of Caucasian patients with hepatocellular carcinoma M.A. Thelu, J.P. Zarski, D. Dardelet, F. Lunel and J.M. Seigneurin (France) Prevalence of hepatitis C virus among non-A, non-B-related chronic liver disease in Egypt A. El-Zayadi, O. Selim, M. Rafik and S. El-Haddad (Egypt) Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation H. Tilg, U. Westhoff, W. Vogel, W.E. Aulitzky, M. Herold, R. Margreiter, C. Huber and H. Grosse-Wilde (Austria, Germany) Lymphoblastoid interferon in chronic hepatitis C patients, ‘non-responders’ to recombinant interferon-a (rIFN-a) L. Cimino, C. Citarella, G. Nardone and G. Budillon (Italy) Announcements Forthcoming papers Author Index (Vol. 14) Subject Index (Vol. 14) Table of Contents (Vol. 14) Errata